Advertisement
Home »

Association study of the complement component C4 gene and suicide risk in schizophrenia.

Feb 12, 2024

ABOUT THE EXPERTS

  • Mahbod Ebrahimi

    Tanenbaum Centre for Pharmacogenetics, Molecular Brain Science, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.

    Institute of Medical Science, University of Toronto, Toronto, Canada.

    Kowsar Teymouri

    Tanenbaum Centre for Pharmacogenetics, Molecular Brain Science, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.

    Institute of Medical Science, University of Toronto, Toronto, Canada.

    Cheng C Chen

    Tanenbaum Centre for Pharmacogenetics, Molecular Brain Science, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.

    Institute of Medical Science, University of Toronto, Toronto, Canada.

    Ayeshah G Mohiuddin

    Tanenbaum Centre for Pharmacogenetics, Molecular Brain Science, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.

    Jennie G Pouget

    Tanenbaum Centre for Pharmacogenetics, Molecular Brain Science, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.

    Department of Psychiatry, University of Toronto, Toronto, Canada.

    Vanessa F Goncalves

    Tanenbaum Centre for Pharmacogenetics, Molecular Brain Science, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.

    Institute of Medical Science, University of Toronto, Toronto, Canada.

    Department of Psychiatry, University of Toronto, Toronto, Canada.

    Department of Pharmacology and Toxicology, University of Toronto, Toronto, Canada.

    Arun K Tiwari

    Tanenbaum Centre for Pharmacogenetics, Molecular Brain Science, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.

    Department of Psychiatry, University of Toronto, Toronto, Canada.

    Clement C Zai

    Tanenbaum Centre for Pharmacogenetics, Molecular Brain Science, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada.

    Institute of Medical Science, University of Toronto, Toronto, Canada.

    Department of Psychiatry, University of Toronto, Toronto, Canada.

    Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Canada.

    James L Kennedy

    Tanenbaum Centre for Pharmacogenetics, Molecular Brain Science, Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Canada. jim.kennedy@camh.ca.

    Institute of Medical Science, University of Toronto, Toronto, Canada. jim.kennedy@camh.ca.

    Department of Psychiatry, University of Toronto, Toronto, Canada. jim.kennedy@camh.ca.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement